Star Pacific Tbk vs Merck Tbk. — how do they compare? Star Pacific Tbk trades at Rp250 (market cap 278.56B, 813.5K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 6.1× Star Pacific Tbk's market cap, and Star Pacific Tbk is more actively traded (813.5K versus 37.6K). Which is the better fit depends on your goals.
| LPLI | MERK | |
|---|---|---|
Market Cap | 278.56B | 1.7T |
Volume | 813.5K | 37.6K |
Lot | 8.14K | 376 |
Turnover | 204.32M | 144.47M |
Average Price | 251.17 | 3,842.23 |
Value | 204.32M | 144.47M |
Indicative Equilibrium Price | 250 | 3,840 |
Indicative Equilibrium Volume | 70 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Star Pacific Tbk (the Company), was established under the name of PT Asuransi Lippo Jiwa Sakti based on Deed No. 301 dated May 28, 1983 of Misahardi Wilamarta, S.H., a notary in Jakarta, which was amended by Deed No. 130 dated August 10, 1983 by the same notary, concerning the change of the Company's name to PT Asuransi Lippo Life. Furthermore, the Company's name was again changed to Lippo E-Net Tbk based on Deed No. 87 dated June 23, 2000 of Misahardi Wilamarta, S.H., a notary in Jakarta.
Read more on LPLI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →